We're thrilled to announce that we've just received FDA approval to launch our Phase II clinical trial targeting a common but often misunderstood form of age-related hearing loss. This milestone represents years of research and brings us one step closer to helping millions of people who struggle with hearing difficulties that traditional hearing aids simply cannot address.
The Hidden Challenge: When Your Brain, Not Your Ears, Is the Problem
Picture this: you're sitting in your favorite restaurant, trying to catch up with an old friend over dinner. The ambiance is lively, conversations buzz at neighboring tables, and despite your best efforts, you find yourself constantly asking "What did you say?" It's not that you can't hear—the sounds are reaching your ears just fine. The problem lies deeper, in the complex neural circuits of your brain that process and make sense of all that incoming auditory information.
-
This type of hearing difficulty affects millions of older adults and represents a fundamentally different challenge from the hearing loss that hearing aids are designed to treat. While hearing aids amplify sound to compensate for damaged hair cells in the ear, they can't fix the age-related changes that occur in the brain's auditory processing centers.
Understanding Central Auditory Processing
Your hearing system is far more sophisticated than just your ears. There's an entire neural network—a "brain attached to these ears"—whose job is to process and compute all the sound information streaming in every second. This auditory processing system performs remarkable feats: it can isolate your friend's voice from the cacophony of a busy restaurant, distinguish between important sounds and background noise, and help you focus on what matters most in complex acoustic environments.
As we age, changes in these brain circuits can significantly impact our ability to process sound effectively. The result? Difficulty following conversations in noisy environments, trouble distinguishing between similar sounds, and frustration in social situations that were once effortless to navigate.
A Revolutionary Approach: Combining Medicine and Sound Engineering
Our upcoming Phase II trial will test an innovative combination treatment that targets the brain's auditory processing capabilities directly. This approach pairs a carefully selected pharmaceutical intervention with specially engineered sound therapy—a dual strategy designed to work synergistically to restore neural function.
What makes this treatment particularly exciting is its potential for lasting impact. We hypothesize that just one month of this combination therapy could restore auditory processing abilities, with benefits persisting for years. If our hypothesis proves correct, this could transform the landscape of age-related hearing loss treatment.
The Science Behind the Solution
The engineered sound component of our treatment isn't just any audio—it's precisely designed based on our understanding of how the auditory brain processes information. These therapeutic sounds are crafted to stimulate and repair the neural pathways involved in auditory processing, while the pharmaceutical component works to support the brain's ability to adapt and heal.
This represents a paradigm shift from simply amplifying sound (the hearing aid approach) to actually repairing and restoring the brain's natural ability to process complex auditory environments.
Join Us in Making History
We're actively preparing to begin recruitment for this groundbreaking trial, with enrollment starting within the next month. This is an unprecedented opportunity to be part of research that could benefit not only you but countless others facing similar challenges.
Are you interested in participating? Here's what you need to know:
The trial will test a one-month combination treatment
We're looking for participants experiencing difficulty isolating speech in noisy environments aged 45-65
This treatment targets brain-based hearing difficulties, not peripheral hearing loss
Potential benefits may last for several years
If you're experiencing the type of hearing difficulties we've described—particularly trouble following conversations in restaurants, meetings, or other noisy environments—we encourage you to reach out.
How to Get Involved
To ensure you're contacted when recruitment begins, please email us. Our team will add you to our priority contact list and reach out with detailed information about eligibility criteria, study procedures, and next steps as soon as enrollment opens.
This FDA approval represents more than just a regulatory milestone—it's a beacon of hope for millions of people who have been told "there's nothing that can be done" about their hearing difficulties in noisy environments. We're on the cusp of potentially changing that narrative forever.
Stay tuned for updates as we move forward with this exciting research. Together, we're not just studying hearing loss—we're working to restore one of our most fundamental connections to the world around us.
For more information about our research or to express interest in participation, contact us at volunteer@parley-neuro.com. Follow our progress as we work to bring this innovative treatment from the laboratory to patients who need it most.